LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 33 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $47,931,000 | +0.1% | 47,643,000 | 0.0% | 0.45% | +8.0% |
| Q3 2021 | $47,881,000 | +14.5% | 47,643,000 | +12.5% | 0.41% | +29.9% |
| Q2 2021 | $41,803,000 | +14.9% | 42,343,000 | +21.2% | 0.32% | +3.2% |
| Q1 2021 | $36,387,000 | +90.8% | 34,938,000 | +74.1% | 0.31% | +120.0% |
| Q4 2020 | $19,071,000 | -30.2% | 20,073,000 | -33.3% | 0.14% | -42.4% |
| Q3 2020 | $27,317,000 | +4.3% | 30,073,000 | 0.0% | 0.24% | -7.6% |
| Q2 2020 | $26,187,000 | +41.7% | 30,073,000 | +36.0% | 0.26% | -1.9% |
| Q1 2020 | $18,483,000 | -41.8% | 22,114,000 | -39.6% | 0.27% | -27.4% |
| Q4 2019 | $31,784,000 | +11.4% | 36,633,000 | +7.3% | 0.37% | +1.9% |
| Q3 2019 | $28,530,000 | +10.9% | 34,133,000 | +14.5% | 0.36% | +7.7% |
| Q2 2019 | $25,720,000 | – | 29,799,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |